TREM2 and Alzheimer disease: Taken in combination with the observation that TREM2 loss of function increases AD risk, this suggests that enhancing TREM2 signaling represents a therapeutic strategy that is downstream of the initial Aβ‐mediated trigger of the amyloid cascade.